ＳＨＰ２アンタゴニストとしてのカルボキサミド－ピリミジン誘導体

Japanese Patent JP2022524759

A

本発明は、一般式Ｉのカルボキサミド－ピリミジン誘導体、又はその薬学的に許容される塩、並びに哺乳動物、特にヒトにおける高増殖性疾患及び障害の治療のための本発明の化合物の使用、並びにそのような化合物を含有する医薬組成物に関する。JPEG2022524759000237.jpg46170

JP5671545	C-linked hydroxamic acid derivative useful as an antibacterial agent
WO/2004/105754	NITROOXYDERIVATIVES OF FLUVASTATIN, PRAVASTATIN, CERIVASTATIN, ATORVASTATIN AND ROSUVASTATIN AS CHOLESTEROL-REDUCING AGENTS WITH IMPROVED ANTI-INFLAMMATORY, ANTITHROMBOTIC AND ANTIPLATELET ACTIVITY
JP2001106675	4-SUBSTITUTED PHENYL-5-HALOPYRIMIDINE DERIVATIVE AND HERBICIDE USING THE SAME AS EFFECTIVE INGREDIENT

Catherine Jolan-Le Blanc
Rock Boisban
Igor Mocharkin
Terisa Johnson
Nina Linde
Drain monsieur
Deepak Kumar

JP2021553031A

May 10, 2022

March 09, 2020

Click for automatic bibliography generation  

Merck Patent Gesellschaft mit beschraenkter Haftung

C07D239/42; A61K31/44; A61K31/506; A61K39/395; A61K45/00; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P3/00; A61P7/00; A61P11/00; A61P11/02; A61P11/04; A61P13/00; A61P13/08; A61P13/10; A61P13/12; A61P15/00; A61P17/00; A61P17/06; A61P19/02; A61P19/08; A61P21/00; A61P25/00; A61P27/02; A61P27/16; A61P29/00; A61P35/00; A61P35/02; A61P37/02; A61P37/08; A61P43/00; C07D239/49; C07D401/04; C07D401/12; C07D401/14; C07D403/04; C07D405/14; C07D413/04; C07D413/14; C07D451/02; C07D487/04; C07D487/08; C07D491/107; C07D491/20; C07D498/04

Aoki Atsushi
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Tatsunori Ikeda
Kazumi Nakamura

Previous Patent: Processes and methods for regenerating flammable and non-flammable hydrofluoroolefin-containing refr...

Next Patent: Bioresponsive antibody complex for enhanced immunotherapy